α-glucosidase inhibitors for patients with type 2 diabetes: Response to van de Laar et al.

Diabetes Care

Volumn 28, Issue 7, 2005, Pages 1840-1841

  Hanefeld, Markolf ^a   Josse, Robert G ^b   Chiasson, Jean Louis ^c   Van De Laar, Floris A ^d   Lucassen, Peter L ^d  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; PLACEBO;

BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE REGIMEN; GLUCOSE INTOLERANCE; HUMAN; META ANALYSIS; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ALPHA-GLUCOSIDASES; DIABETES MELLITUS, TYPE 2; ENZYME INHIBITORS; HUMANS; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS;

EID: 21544448591     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.7.1840     Document Type: Note

References (0)